A skincare ingredient list and a research-vial label can both contain the word peptide while describing very different products. The useful comparison is not whether the word appears on both labels. It is whether the exact molecule, formulation, exposure and measured outcome match the evidence being cited.
The finished formula is part of the experiment
A cosmetic formula includes a vehicle: the surrounding cream, serum or other preparation carrying the ingredient. In a well-designed comparison, researchers try to separate an ingredient's contribution from the effects of that surrounding formula. Comparing a peptide cream with no skincare at all would leave more possible explanations than comparing it with an otherwise matched vehicle.
For example, an original palmitoyl-pentapeptide study enrolled 93 women aged 35–55 in a 12-week, double-blind, randomised split-face comparison. The same moisturiser with and without the studied ingredient was compared on opposite sides of the face. The authors reported improvements in selected wrinkle assessments. The participants, formulation, duration and measurements define the scope; the study does not establish the performance of every cosmetic peptide or research preparation.
Keep the product categories separate
| Product | Evidence to identify | Invalid shortcut |
|---|---|---|
| Finished cosmetic | Exact formula, intended appearance-related outcome and comparison | Assuming an ingredient study validates every cream containing it |
| Laboratory research material | Molecular identity, analytical measurements and experimental suitability | Treating purity as proof of cosmetic or therapeutic performance |
| Therapeutic product | Specific formulation, indication and applicable regulatory evidence | Transferring approval to an unrelated vial with a similar name |
What do signal, carrier and other peptide labels mean?
These labels describe a proposed function or a formulation role; they are not interchangeable trial results. When a source calls an ingredient a signal peptide, ask which signal was measured and in what system. When it describes a metal-binding or carrier role, ask what chemical complex was actually tested. A proposed mechanism gives you a question to investigate, not a ready-made conclusion about a finished serum.
Apply the same reasoning to claims about delivery. A skin study does not test an oral or injectable preparation. A change in route changes the experimental question, so evidence needs to follow the actual product and exposure. This is why mixing a research material into a cosmetic or interpreting a cosmetic study as administration guidance is not a scientifically supported inference.
Australian classification depends on more than the bottle
The TGA's classification guidance explains that composition, presentation and claims can affect whether a product is a cosmetic or therapeutic good. A claim about treating a condition can have a different regulatory meaning from a claim about appearance. The whole presentation matters, including images and advertising context.
AICIS explains the cosmetic boundary and the role of industrial-chemical regulation. Its framework should not be mistaken for TGA assessment of a medicine. Likewise, the FDA's US explanation distinguishes cosmetic and drug purposes; it is useful context, not the governing rule for Australia.
A short reading exercise
Take one skincare claim and write four fields: exact formula, comparator, people studied and measured outcome. If the reference describes a different ingredient or an experiment in cells, mark the mismatch. Then distinguish an observed change from the proposed explanation for that change. This simple record makes it easier to appreciate a useful cosmetic study without extending it beyond what its authors measured.
Also record the follow-up period. A result measured during a short study does not tell you how long it persists after use stops unless the investigators actually measured that question.